Curebound Aims to Accelerate Cancer Cures Amid NIH Funding Cuts
Curebound, under the leadership of COO Karen Hooper, is intensifying efforts to fund innovative cancer research, especially critical in light of recent NIH funding cuts, to accelerate cures within our lifetime.
